Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VEENA S JOHN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1356475610
CMS profile
629489
Location
LAKE SUCCESS, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,749.00

3 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,665.00 1
Food and Beverage $84.00 2

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $2,665.00 1
Eli Lilly and Company $57.00 1
Lilly USA, LLC $27.00 1

Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VEENA S JOHN

NPI 1356475610 · CMS profile ID 629489

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

LAKE SUCCESS, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1356475610?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VEENA S JOHN, NPI 1356475610, CMS profile ID 629489. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1356475610?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). VEENA S JOHN, NPI 1356475610, CMS profile ID 629489. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1356475610?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
VEENA S JOHN, NPI 1356475610, CMS profile ID 629489, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–3 of 3 matching records. This page contains 3 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1356475610?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

3 matching records · $2,749.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 3 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–3 of 3.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $2,665.0012/09/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1215351168 CMS
Lilly USA, LLC $27.0006/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186991930 CMS
Eli Lilly and Company $57.0005/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186956203 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $2,397.50 1
PY2021 $3,384.92 4
PY2022 $8,314.43 8
PY2023 $282.38 3
PY2024 $5,280.14 4
PY2025 $2,749.00 3

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $117,539.27 115
PY2024 Principal investigator $75,315.93 37
PY2023 Principal investigator $181,942.68 17
PY2022 Principal investigator $644,386.95 38
PY2021 Principal investigator $521,972.74 85
PY2020 Principal investigator $281,344.94 58
PY2019 Principal investigator $495,433.48 82

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

115 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $543.06 12/04/2025 Non-covered Recipient Entity
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) No dispute reported 06/30/2026 1202528084
Principal investigator 1 GlaxoSmithKline, LLC. $5,712.00 11/24/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192130786
Principal investigator 1 GlaxoSmithKline, LLC. $2,212.47 11/06/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192130759
Principal investigator 1 GlaxoSmithKline, LLC. $1,105.00 11/06/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192132868
Principal investigator 1 Daiichi Sankyo Inc. $17.70 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374897
Principal investigator 1 Daiichi Sankyo Inc. $70.80 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374899
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374901
Principal investigator 1 Daiichi Sankyo Inc. $39.45 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374903
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374905
Principal investigator 1 Daiichi Sankyo Inc. $13.15 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374907
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374909
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374911
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374913
Principal investigator 1 Daiichi Sankyo Inc. $131.50 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374915
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374917
Principal investigator 1 Daiichi Sankyo Inc. $26.30 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374919
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374921
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374923
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374925
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374927
Principal investigator 1 Daiichi Sankyo Inc. $52.60 10/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374929
Principal investigator 1 GlaxoSmithKline, LLC. $1,162.47 09/18/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192132879
Principal investigator 1 Daiichi Sankyo Inc. $63.70 09/16/2025 Non-covered Recipient Entity
The Feinstein Institute For Medical Research
DS600-109 No dispute reported 06/30/2026 1223385353
Principal investigator 1 GlaxoSmithKline, LLC. $1,105.00 09/04/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192130774
Principal investigator 1 GlaxoSmithKline, LLC. $1,105.00 09/04/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192130793
Principal investigator 1 Daiichi Sankyo Inc. $40,000.00 08/14/2025 Non-covered Recipient Entity
The Feinstein Institute For Medical Research
DS600-109 No dispute reported 06/30/2026 1223385351
Principal investigator 1 Daiichi Sankyo Inc. $52.60 08/04/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374749
Principal investigator 1 Daiichi Sankyo Inc. $52.60 08/04/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374751
Principal investigator 1 Daiichi Sankyo Inc. $70.80 08/04/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374753
Principal investigator 1 Daiichi Sankyo Inc. $52.60 08/04/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374755
Principal investigator 1 Daiichi Sankyo Inc. $105.20 08/04/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374757
Principal investigator 1 Daiichi Sankyo Inc. $52.60 08/04/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374759
Principal investigator 1 Daiichi Sankyo Inc. $52.60 08/04/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374761
Principal investigator 1 Daiichi Sankyo Inc. $52.60 08/04/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374763
Principal investigator 1 ABBVIE INC. $2,683.17 07/22/2025 Non-covered Recipient Entity
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) No dispute reported 06/30/2026 1202499160
Principal investigator 1 Daiichi Sankyo Inc. $17.70 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374739
Principal investigator 1 Daiichi Sankyo Inc. $45.61 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374741
Principal investigator 1 Daiichi Sankyo Inc. $43.94 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374743
Principal investigator 1 Daiichi Sankyo Inc. $43.94 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374745
Principal investigator 1 Daiichi Sankyo Inc. $43.94 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374747
Principal investigator 1 Daiichi Sankyo Inc. $43.94 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374765
Principal investigator 1 Daiichi Sankyo Inc. $35.40 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374767
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374769
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374771
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374773
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374775
Principal investigator 1 Daiichi Sankyo Inc. $22.71 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374777
Principal investigator 1 Daiichi Sankyo Inc. $22.71 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374779
Principal investigator 1 Daiichi Sankyo Inc. $22.71 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374781
Principal investigator 1 Daiichi Sankyo Inc. $31.56 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374783
Principal investigator 1 Daiichi Sankyo Inc. $31.56 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374785
Principal investigator 1 Daiichi Sankyo Inc. $45.61 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374787
Principal investigator 1 Daiichi Sankyo Inc. $45.61 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374789
Principal investigator 1 Daiichi Sankyo Inc. $44.50 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374791
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374793
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374795
Principal investigator 1 Daiichi Sankyo Inc. $35.40 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374797
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374799
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374801
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374803
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374805
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374807
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374809
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374811
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374813
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374815
Principal investigator 1 Daiichi Sankyo Inc. $17.70 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374817
Principal investigator 1 Daiichi Sankyo Inc. $17.70 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374819
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374821
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374823
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374825
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374827
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374829
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374831
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374833
Principal investigator 1 Daiichi Sankyo Inc. $52.60 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374835
Principal investigator 1 Daiichi Sankyo Inc. $52.60 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374837
Principal investigator 1 Daiichi Sankyo Inc. $52.60 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374839
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374841
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374843
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374845
Principal investigator 1 Daiichi Sankyo Inc. $28.75 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374847
Principal investigator 1 Daiichi Sankyo Inc. $28.75 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374849
Principal investigator 1 Daiichi Sankyo Inc. $3.90 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374851
Principal investigator 1 Daiichi Sankyo Inc. $3.90 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374853
Principal investigator 1 Daiichi Sankyo Inc. $3.90 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374855
Principal investigator 1 Daiichi Sankyo Inc. $40.59 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374857
Principal investigator 1 Daiichi Sankyo Inc. $40.59 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374859
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374861
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374863
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374865
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374867
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374869
Principal investigator 1 Daiichi Sankyo Inc. $17.70 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374871
Principal investigator 1 Daiichi Sankyo Inc. $17.70 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374873
Principal investigator 1 Daiichi Sankyo Inc. $17.70 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374875
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374877
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374879
Principal investigator 1 Daiichi Sankyo Inc. $44.50 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374881
Principal investigator 1 Daiichi Sankyo Inc. $44.50 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374883
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374885
Principal investigator 1 Daiichi Sankyo Inc. $31.56 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374887
Principal investigator 1 Daiichi Sankyo Inc. $26.30 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374889
Principal investigator 1 Daiichi Sankyo Inc. $40.59 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374891
Principal investigator 1 Daiichi Sankyo Inc. $28.75 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374893
Principal investigator 1 Daiichi Sankyo Inc. $13.15 07/01/2025 Non-covered Recipient Entity
Northwell Health Zuckerberg Cancer Center
DS600-109 No dispute reported 06/30/2026 1223374895
Principal investigator 1 ABBVIE INC. $14,980.77 05/12/2025 Non-covered Recipient Entity
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) No dispute reported 06/30/2026 1202484643
Principal investigator 1 GlaxoSmithKline, LLC. $2,040.00 04/17/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192130747
Principal investigator 1 ABBVIE INC. $1,544.04 04/14/2025 Non-covered Recipient Entity
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) No dispute reported 06/30/2026 1202476299
Principal investigator 1 ABBVIE INC. $299.68 04/14/2025 Non-covered Recipient Entity
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) No dispute reported 06/30/2026 1202476303
Principal investigator 1 ABBVIE INC. $33,000.00 04/14/2025 Non-covered Recipient Entity
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) No dispute reported 06/30/2026 1202476306
Principal investigator 1 GlaxoSmithKline, LLC. $1,980.11 03/20/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192130753
Principal investigator 1 GlaxoSmithKline, LLC. $479.89 03/20/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192132873
Principal investigator 1 GlaxoSmithKline, LLC. $2,212.47 02/20/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192130768
Principal investigator 1 GlaxoSmithKline, LLC. $2,212.47 01/09/2025 Non-covered Recipient Entity
BIOMEDICAL RESEARCH ALLIANCE OF NEW YORK LLC
AN OPEN-LABEL, MULTICENTER, LONG-TERM TREATMENT EXTENSION STUDY IN SUB No dispute reported 06/30/2026 1192130780